S&P Futures
4,261.50+5.50(+0.13%)Dow Futures
34,214.00+132.00(+0.39%)Nasdaq Futures
14,362.75+8.50(+0.06%)
Harrow Health, Inc. (HROW)
Chart Events
Performance Outlook
| Previous Close | 9.87 |
| Open | 10.18 |
| Bid | 0.00 x 2200 |
| Ask | 0.00 x 800 |
| Day's Range | 10.11 - 10.72 |
| 52 Week Range | 4.65 - 11.24 |
| Volume | 631,160 |
| Avg. Volume | 242,781 |
| Market Cap | 277.252M |
| Beta (5Y Monthly) | 0.91 |
| PE Ratio (TTM) | 27.89 |
| EPS (TTM) | 0.37 |
| Earnings Date | Aug 09, 2021 - Aug 13, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.00 |
- Zacks
Harrow (HROW) Surges 12%: Is This an Indication of Further Gains?
Harrow (HROW) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- GlobeNewswire
Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
NASHVILLE, Tenn., June 17, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the closing of its underwritten registered public offering of $20 million aggregate principal amount of 8.625% senior notes due 2026 (the “Notes”), which includes the full exercise of the over-allotment option of $2.5 million aggregate principal amount granted to the underwriters. The Notes will be treated as a single
- GlobeNewswire
Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
NASHVILLE, Tenn., June 14, 2021 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) (“Harrow Health” or the “Company”), an ophthalmic-focused healthcare company, today announced the pricing of its underwritten registered public offering of $17.5 million aggregate principal amount of 8.625% senior notes due 2026 (the “Notes”). The Company has granted the underwriters a 30-day option to purchase an additional $2.5 million aggregate principal amount of Notes in connection with the offering. The
